The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis

J Inflamm Res. 2024 Feb 19:17:1105-1120. doi: 10.2147/JIR.S444758. eCollection 2024.

Abstract

Arthritis is the most prevalent joint disease and is characterized by articular cartilage degradation, synovial inflammation, and changes in periarticular and subchondral bone. Recent studies have reported that Yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) have significant effects on the proliferation, migration, and survival of chondrocytes and fibroblast-like synovial cells (FLSs). YAP/TAZ signaling pathway, as well as the related Hippo-YAP signaling pathway, are responsible for the condition of cells and articular cartilage in joints. They are tightly regulated to maintain metabolism in chondrocytes and FLSs because abnormal expression may result in cartilage damage. However, the roles and mechanisms of the Hippo-YAP pathway in arthritis remain largely unknown. This review summarizes the roles and key functions of YAP/TAZ and the Hippo-YAP signaling pathway in FLSs and chondrocytes for the induction of proliferation, migration, survival, and differentiation in rheumatoid arthritis (RA) and osteoarthritis (OA) research. We also discuss the therapeutic strategies involving YAP/TAZ and the related Hippo-YAP signaling pathway involved in OA.

Keywords: YAP/TAZ; chondrocytes; osteoarthritis; rheumatoid arthritis; therapy.

Publication types

  • Review

Grants and funding

This work was supported by the Natural Science Foundation of Changsha City (No. kq2208380), the Natural Science Foundation of Wuxi City (No. k20231060), the youth talent project of Wuxi health commission (No. Q202150), Duo-Innovative and Excellent Doctors Project of Wuxi 9th People’s Hospital (No. YB20210) and the Top Talent Support Program for young and middle-aged people of Wuxi Health Committee (No, HB2023125).